Visx Eyes Expanded CustomVue Indications, Readies U.S. Presbyopia Trial
Visx is counting on expanded hyperopia and myopia claims to its CustomVue wavefront ablation system to spur 8%-10% sales growth in 2005
Visx is counting on expanded hyperopia and myopia claims to its CustomVue wavefront ablation system to spur 8%-10% sales growth in 2005